vers la météo de la validation par utilisateur

Ingenuity377

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 52 - PMID ?

__NODE__ , an inhibitor of __SP__ __NODE__ protein , is in Phase II clinical trial to treat lymphoma .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
                                                       +---------------COMP:V-N(in)--------------+     
     +---------------------SUBJ:V-N--------------------+           +---------MOD_ATT:N-N---------+     
     |             +--------COMP:N-N(of)-------+       |           |     +-----MOD_ATT:N-ADJ-----+     
     |             |           +-MOD_ATT:N-ADJ-+       |           |     |      +---MOD_ATT:N-N--+     
     +----APPOS----+           |       +MOD_ATT+       |           |     |      |        +MOD_ATT+     
     |             |           |       |       |       |           |     |      |        |       |     
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , is in Phase II clinical trial to treat lymphoma .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,lymphoma)
MOD_ATT:N-N (lymphoma,II)
MOD_ATT:N-ADJ (lymphoma,clinical)
MOD_ATT:N-N (lymphoma,trial)
MOD_ATT:N-N (lymphoma,treat)
Analyse 1 
                                                       +---------------COMP:V-N(in)--------------+     
                                                       |      +------------MOD_ATT:N-N-----------+     
     +---------------------SUBJ:V-N--------------------+      |    +---------MOD_ATT:N-N---------+     
     |             +--------COMP:N-N(of)-------+       |      |    |     +-----MOD_ATT:N-ADJ-----+     
     |             |           +-MOD_ATT:N-ADJ-+       |      |    |     |      +---MOD_ATT:N-N--+     
     +----APPOS----+           |       +MOD_ATT+       |      |    |     |      |        +MOD_ATT+     
     |             |           |       |       |       |      |    |     |      |        |       |     
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , is in Phase II clinical trial to treat lymphoma .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,lymphoma)
MOD_ATT:N-N (lymphoma,phase)
MOD_ATT:N-N (lymphoma,II)
MOD_ATT:N-ADJ (lymphoma,clinical)
MOD_ATT:N-N (lymphoma,trial)
MOD_ATT:N-N (lymphoma,treat)
Analyse 2 
                                                       +---------------COMP:V-N(in)--------------+     
     +---------------------SUBJ:V-N--------------------+           +---------MOD_ATT:N-N---------+     
     |             +--------COMP:N-N(of)-------+       |           |     +-----MOD_ATT:N-ADJ-----+     
     |             |           +-MOD_ATT:N-ADJ-+       |           |     |      +---MOD_ATT:N-N--+     
     +----APPOS----+           |       +MOD_ATT+       |           |     |      |        +MOD_ATT+     
     |             |           |       |       |       |           |     |      |        |       |     
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , is in Phase II clinical trial to treat lymphoma .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,lymphoma)
MOD_ATT:N-N (lymphoma,II)
MOD_ATT:N-ADJ (lymphoma,clinical)
MOD_ATT:N-N (lymphoma,trial)
MOD_ATT:N-N (lymphoma,treat)
Analyse 3 
                                                       +---------------COMP:V-N(in)--------------+     
                                                       |      +------------MOD_ATT:N-N-----------+     
     +---------------------SUBJ:V-N--------------------+      |    +---------MOD_ATT:N-N---------+     
     |             +--------COMP:N-N(of)-------+       |      |    |     +-----MOD_ATT:N-ADJ-----+     
     |             |           +-MOD_ATT:N-ADJ-+       |      |    |     |      +---MOD_ATT:N-N--+     
     +----APPOS----+           |       +MOD_ATT+       |      |    |     |      |        +MOD_ATT+     
     |             |           |       |       |       |      |    |     |      |        |       |     
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , is in Phase II clinical trial to treat lymphoma .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,lymphoma)
MOD_ATT:N-N (lymphoma,phase)
MOD_ATT:N-N (lymphoma,II)
MOD_ATT:N-ADJ (lymphoma,clinical)
MOD_ATT:N-N (lymphoma,trial)
MOD_ATT:N-N (lymphoma,treat)